Enhancer and Promoter Atlases

Consortium annotates the human genome with cell type-specific information about transcription start sites, active enhancers, and their expression throughout the body.

Written byAshley P. Taylor
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

NHGRIResearchers at Japan’s RIKEN institute, in collaboration with scientists worldwide, have produced two atlases of genetic regulatory elements throughout the human genome, as reported in a pair of papers published today (March 26) in Nature. The first paper presents an atlas of transcription start sites, where RNA polymerase begins to transcribe DNA into RNA; the second maps active enhancers, non-promoter stretches of DNA that upregulate the transcription of certain genes. Sixteen additional papers related to this work—results from the fifth edition of the Functional Annotation of the Mammalian Genome (FANTOM) project—are also today being published in other journals, including Blood and BMC Genomics.

“Both papers are very significant,” said biochemist Wei Wang from the University of California, San Diego, who was not involved in the work. “This will be a very valuable resource for the community.”

“We made an encyclopedia of the definition of the normal cell: 185,000 promoters, 44,000 enhancers, and the majority of them are tissue-specific,” said the RIKEN Omics Science Center’s Yoshihide Hayashizaki, who led the promoter annotation project.

“This is a very broad survey of transcriptional activity in diverse cell types, [making it] a very valuable resource, and currently, quite unique,” said Zhiping Weng from the University of Massachusetts Medical School, who was not involved in the work. Weng noted that the only comparable resource is the Genotype-Tissue Expression Program (GTEX), which when compared ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies